GE Aerospace vs Select Medical Holdings Corporation — how do they compare? GE Aerospace trades at $339.67 (market cap $375.97B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: GE Aerospace is far larger — about 183.4× Select Medical Holdings Corporation's market cap, and Select Medical Holdings Corporation pays the higher dividend (1.51%). Which is the better fit depends on your goals.
| GE | SEM | |
|---|---|---|
Market Cap | $375.97B | $2.05B |
Sector | Industrials | Health |
52-Week High | $378.68 | $16.66 |
52-Week Low | $259.00 | $11.77 |
Enterprise Value | $385.26B | $5.01B |
Dividend Yield | 0.52% | 1.51% |
Signals from Pluang's Aura AI — not financial advice
GE trades at $353.73, up 0.09% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q1 2026 EPS of $1.86 versus $1.60 expected, driven by robust aerospace demand and defense contract wins. Revenue grew to $45.86 billion in 2025, with net income margin improving to 18.98%. Analysts maintain a strong buy consensus with a $402.63 price target, reflecting optimism about order growth and backlog strength.
Outlook remains positive given earnings momentum and strategic investments in MRO and propulsion, though high valuation ratios (P/E 43.94) and debt levels pose risks. The stock offers upside to consensus targets but faces pressure from rising costs and competitive dynamics in aerospace and defense sectors.
Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. Recent earnings show volatility with Q3 2025 beating estimates but Q1 2026 missing, while valuation ratios like P/E of 15.43 and P/S of 0.36 suggest moderate pricing. The company announced a $0.06 dividend for H1 2026, but news highlights its acquisition completion by a consortium led by Robert A. Ortenzio in June 2026, with legal investigations into the fairness of the $16.50 per share deal.
The outlook is clouded by acquisition-related uncertainties and legal scrutiny, posing risks to shareholder value. Analyst consensus leans neutral with 57.15% hold ratings, reflecting cautious sentiment amid the takeover. Investors should weigh the stable fundamentals against potential dilution or litigation outcomes, with the stock's near-term direction tied to resolution of these corporate actions.
Trailing returns across standard periods
Latest headlines on both assets
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →